National
India to continue hydroxychloriquine use against COVID-19 even as WHO pauses drug’s trial
The ICMR’s statement came against the backdrop of the World Health Organization (WHO) suspending the testing of the drug in COVID-19 patients temporarily in its global study. PTI No major side-effects of hydroxychloriquine have been found in studies in India and its use should be continued in preventive treatment